About
In addition to the standard bioinformatics analyses provided by Oncolines, we offer customized bioinformatics services tailored to meet the specific needs of your project. Our custom analyses cover a wide range of applications aimed to derive meaningful insights from complex biological data. The Oncolines bioinformatics team can support your project by selecting the most relevant cell line models for in vitro studies, conducting in silico explorations of clinical datasets, or analyzing next-generation sequencing datasets. Please contact us to discuss your project’s needs and learn how our custom bioinformatics services can advance your project.
Type
- Development
- Consulting
Applies to
- Innovative therapies - Immune cell therapy
- Innovative therapies - Precision medicine
- Innovative human-based test models - 2D & 3D in vitro cell culture models
- Innovative human-based test models - 3D spheroids
- Development stages and support fuctions - Early discovery / basic research
- Development stages and support fuctions - Technology development and validation
- Development stages and support fuctions - Pre-clinical research and development
Organisation
Similar opportunities
Service
- Consulting
- Development
- Innovative therapies - Nanomedicine
- Innovative therapies - Precision medicine
- Innovative therapies - Immune cell therapy
- Innovative human-based test models - 3D spheroids
- Innovative human-based test models - 2D & 3D in vitro cell culture models
- Development stages and support fuctions - Clinical research and development
- Development stages and support fuctions - Pre-clinical research and development
Guido Zaman
Managing Director at Oncolines B.V.
Oss, Netherlands
Service
Oncolines cancer cell panel profiling
- Consulting
- Development
- Innovative therapies - Precision medicine
- Innovative therapies - Immune cell therapy
- Innovative human-based test models - 3D spheroids
- Innovative human-based test models - 2D & 3D in vitro cell culture models
- Development stages and support fuctions - Clinical research and development
- Development stages and support fuctions - Pre-clinical research and development
Guido Zaman
Managing Director at Oncolines B.V.
Oss, Netherlands
Product
EDDI - Epigenetic Digital Data Interface
- Innovative therapies - RNA therapy
- Innovative therapies - Gene therapy
- Innovative therapies - Gene editing
- Innovative therapies - Nanomedicine
- Innovative therapies - Stem cell therapy
- Innovative therapies - Oncolytic viruses
- Innovative therapies - Microbiome therapy
- Innovative therapies - Precision medicine
- Innovative therapies - Immune cell therapy
- Innovative therapies - Somatic cell therapy
- Innovative therapies - Tissue engineered products
- Innovative human-based test models - 3D spheroids
- Innovative human-based test models - 3D spheroids
- Innovative human-based test models - Organ-on-Chip
- Innovative human-based test models - In silico human models
- Development stages and support fuctions - Regulatory and compliance
- Innovative human-based test models - Bioprinted tissues and constructs
- Development stages and support fuctions - Data management and analytics
- Innovative human-based test models - Assembloids and multi-tissue models
- Development stages and support fuctions - Contract research (CRO / CRMO)
- Innovative human-based test models - 2D & 3D in vitro cell culture models
- Development stages and support fuctions - Early discovery / basic research
- Development stages and support fuctions - Funding, capital and investments
- Development stages and support fuctions - Ethics and social responsibility
- Development stages and support fuctions - Clinical research and development
- Development stages and support fuctions - Development and (GMP) manufacturing
- Development stages and support fuctions - Technology development and validation
- Development stages and support fuctions - Pre-clinical research and development
- Development stages and support fuctions - Commercial strategy and market access
daniel lüscher
CEO at QBDC GmbH
Nusshof, Switzerland